MDA Golf Events to Support Neuromuscular Research, Patient Care
Registration is now open for fundraising events at four championship golf courses, whose fees will be used to…
Articles by Steve Bryson, PhD
#MDA2021 – WVE-004 Treats Causes of ALS Due to C9orf72 Mutations in Early Study
Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 MDA Virtual Clinical and Scientific Conference,…
Shrinkage in Cell Structures Occurs in Early Disease Stages
Changes to a critical structure within the cell nucleus of spinal nerve cells — the nucleolus — preceded…
Compound Reverses Motor Neuron Damage in ALS Mice
For the first time, a compound was able to restore the health of diseased upper motor neurons — nerve cells…
Common Gene Variants Not Found in Maltese ALS Patients
Maltese people with amyotrophic lateral sclerosis (ALS) do not exhibit mutations in the genes commonly…
$2.2M Grant Aims to Move M102, Potential ALS Therapy, Into Trials
Work into moving M102, an investigative treatment for amyotrophic lateral sclerosis…
Experimental Test Could Detect ALS Before Symptom Onset
A method that measures tiny amounts of aggregated TDP-43 protein in the cerebrospinal fluid may have the …
BREN-02, Potential Restorative ALS Therapy, Named Orphan Drug by FDA
BREN-02, a lab-made form of the human protein engrailed 1 (EN1), has…
Stentrode Device Allows Computer Control by ALS Patients With Partial Upper Limb Paralysis
The Stentrode, a minimally invasive, fully implanted wireless device that transmits signals from…
Specific Immune Cell, With Human Equivalent, Seen to Reverse Nerve Damage in Mice
A newly identified type of immune cell — a kind of immature neurophil or white blood cell…